{
    "Case ID": "029480",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement Dispute"
    ],
    "Legal_Issue": [
        "Whether Pharmascience is prohibited from marketing its version of Urso® due to patent infringement"
    ],
    "Governing_Law": [
        "Canadian Patent Act"
    ],
    "Procedural_Stage": [
        "Federal Court proceeding under the Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Evidence_Assessment": [
        "Analysis of prior publications, expert testimonies, and patent claims"
    ],
    "Decision_Outcome": [
        "Patent is invalid; Pharmascience allowed to market its version"
    ],
    "Burden_of_Proof": [
        "On Pharmascience to show patent invalidity"
    ],
    "Credibility_Factor": [
        "Expert testimonies evaluated by the court"
    ],
    "Legal_Rule": [
        "A patent is invalid if the invention was previously known or obvious; methods of medical treatment are not patentable"
    ],
    "Standard_of_Review": [
        "Statutory interpretation and factual assessment under patent law"
    ],
    "Procedural_Issue": [
        "Compliance with Notice of Compliance Regulations"
    ],
    "Grounds_for_Claim": [
        "Prior knowledge of dosage range and unpatentable method of medical treatment"
    ],
    "Outcome_on_Merits": [
        "Axcan’s application dismissed; no prohibition order issued"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Application dismissed"
    ],
    "Review_Standard": [
        "Statutory review under the Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Procedural_Fairness_Assessment": [
        "Court followed proper procedures in evaluating evidence and arguments"
    ],
    "Key_Evidence_Considered": [
        "Prior publications, expert testimony, patent claims"
    ],
    "Legal_Framework": [
        "Patent Act, Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "Axcan sought to prevent Pharmascience from marketing generic Ursodiol"
    ],
    "Court_Result": [
        "Dismissed Axcan’s application"
    ],
    "Legal_Rule_Source": [
        "Canadian Patent Act"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Patent is invalid due to prior art and non-patentable subject matter"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert evidence"
    ],
    "Remedy_Requested": [
        "Prohibition order against Pharmascience"
    ],
    "Outcome": [
        "Pharmascience permitted to market its version of Ursodiol"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Pre-market injunction based on patent validity"
    ],
    "Resolution_Mechanism": [
        "Judicial determination"
    ],
    "Legal_Provision": [
        "Section 41 of the Patent Act, PM(NOC) Regulations"
    ],
    "Authority": [
        "Federal Court"
    ],
    "Claimant_Status": [
        "Patent holder (Axcan)"
    ],
    "Legal_Provision_Cited": [
        "Canadian Patent Act, PM(NOC) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Invalidity due to prior art and non-statutory subject matter"
    ],
    "Applicable_Process": [
        "Notice of Compliance litigation process"
    ],
    "Outcome_of_Review": [
        "Patent found invalid"
    ],
    "Pending_Relief_or_Application": [
        "Application for prohibition order"
    ],
    "Jurisdiction": [
        "Federal jurisdiction – intellectual property"
    ],
    "Governing_Rule": [
        "Patented Medicine (Notice of Compliance) Regulations"
    ]
}